Edition:
India

Kangmei Pharmaceutical Co Ltd (600518.SS)

600518.SS on Shanghai Stock Exchange

22.95CNY
12:29pm IST
Change (% chg)

¥0.04 (+0.17%)
Prev Close
¥22.91
Open
¥22.62
Day's High
¥23.00
Day's Low
¥22.20
Volume
13,360,211
Avg. Vol
15,251,104
52-wk High
¥28.25
52-wk Low
¥19.30

Latest Key Developments (Source: Significant Developments)

Kangmei Pharmaceutical issues 2018 3rd tranche super short-term financing notes worth 2 bln yuan
Tuesday, 22 May 2018 

May 22 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::Says it completed issuance of 2018 3rd tranche super short-term financing notes worth 2 billion yuan with coupon rate of 5.90 percent .  Full Article

Kangmei Pharmaceutical to acquire 100 pct stake in medical firm for 6.1 mln yuan
Friday, 18 May 2018 

May 18(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it will acquire 100 percent stake in a Hubei-based medical company for 6.1 million yuan .  Full Article

Kangmei Pharmaceutical to invest 30 mln yuan to set up two units
Friday, 18 May 2018 

May 18(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it plans to invest 10 million yuan to set up a wholly owned medical technology unit in Shenzhen.Says it plans to invest 20 million yuan to set up a wholly owned unit in Yunnan, which will be mainly engaged in traditional Chinese medicinal materials related business .  Full Article

Kangmei Pharmaceutical Says Board Elects Ma Xingtian As Chairman
Thursday, 17 May 2018 

May 17 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>::SAYS BOARD ELECTS MA XINGTIAN AS CHAIRMAN.  Full Article

Kangmei Pharmaceutical obtains high-tech enterprise recognition again and to enjoy tax preference
Friday, 4 May 2018 

May 4 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it was recognized as high-tech enterprise again and could enjoy a tax preference of 15 percent, from 2017 to 2019 .  Full Article

Kangmei Pharmaceutical Plans Debt Financing Instruments And Bonds, To Invest In Zhuhai Headquarters
Wednesday, 25 Apr 2018 

April 25 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>::SAYS IT PLANS TO ISSUE UP TO 10.0 BILLION YUAN ($1.58 billion) DEBT FINANCING INSTRUMENTS.SAYS IT PLANS TO ISSUE UP TO 6.0 BILLION YUAN BONDS.SAYS IT PLANS TO INVEST 1.1 BILLION YUAN TO BUILD HEADQUARTER BUILDING IN ZHUHAI CITY.  Full Article

Kangmei Pharmaceutical issues 2018 1st tranche short-term financing notes worth 2 bln yuan
Wednesday, 28 Mar 2018 

March 28(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::Says it issued 2018 1st tranche 365 days short-term financing notes worth 2 billion yuan with coupon rate of 5.3 percent.  Full Article

Kangmei Pharmaceutical unit to acquire 80 pct stake in medical instruments firm for 16 mln yuan
Wednesday, 10 Jan 2018 

Jan 10(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says co's Shanghai-based wholly owned pharmaceutical unit plans to acquire 80 percent stake in a Shandong-based medical instruments firm, at the price of 16 million yuan .  Full Article

Kangmei Pharmaceutical to set up two Chinese herbal medicines related units in Yunfu and Tongren
Wednesday, 10 Jan 2018 

Jan 10(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it plans to invest 20 million yuan to set up two Chinese herbal medicines related wholly owned units in Yunfu and Tongren.  Full Article

Kangmei Pharmaceutical to acquire 80 pct stake in Huizhou-based pharmaceutical firm for 20.8 mln yuan
Friday, 29 Dec 2017 

Dec 29(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::Says it plans to acquire 80 percent stake in Huizhou-based pharmaceutical firm for 20.8 million yuan .  Full Article

BRIEF-Kangmei Pharmaceutical issues 2018 first tranche super short-term financing notes worth 1.5 bln yuan

* Says it issued 2018 first tranche super short-term financing notes worth 1.5 billion yuan, with a term of 270 days and coupon rate of 5.38 percent